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Abstract
Background: Mucosa-associated lymphoid tissue lymphomas can occur in various parts of the body, and half of
mucosa-associated lymphoid tissue lymphomas occur in the gastrointestinal tract. Gastric mucosa-associated
lymphoid tissue lymphoma is the most common lymphoma of the gastrointestinal tract and primary rectal mucosa-
associated lymphoid tissue lymphoma is very rare. Because of the high radiosensitivity of mucosa-associated
lymphoid tissue lymphomas, this condition can be controlled with radiotherapy of approximately 30 Gy alone.
However, ovarian dysfunction as an adverse event of radiotherapy for pelvic lesions can become a problem in girls
and women. We report a case of a 28-year-old woman with rectal mucosa-associated lymphoid tissue lymphoma
who safely gave birth to a baby following 30.6 Gy radiotherapy to her whole rectum.
Case presentation: A 28-year-old Japanese woman became aware of bloody stools and was diagnosed as having
Lugano I rectal mucosa-associated lymphoid tissue lymphoma. She was referred to our institute and initiated on
radiotherapy. However, she expressed a desire to bear children. We used horizontally opposed pair fields for
radiotherapy to minimize the irradiation to her endometrium and ovary. A total dose of 30.6 Gy was given in 17
fractions of 1.8 Gy by 10-Megavolt X-ray linear accelerator. As a result, one-third of her uterus and half of her ovary
were outside the irradiation field. After approximately 1 year of treatment, positive pregnancy was confirmed and
finally she safely gave birth to a baby girl without congenital abnormalities.
Conclusions: This report provides hope for girls and women who have undergone irradiation for pelvic mucosa-
associated lymphoid tissue lymphomas and who desire to bear children.
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Background
Mucosa-associated lymphoid tissue (MALT) lymphoma
is a low-grade B cell lymphoma, first identified by
Isaacson and Wright in 1983 [1]. This lymphoma can
occur in various parts of the body, and half of all MALT
lymphomas occur in the gastrointestinal tract. Gastric
MALT lymphoma is the most common gastrointestinal
tract lymphoma, comprising 85% of all cases, and pri-
mary rectal MALT lymphoma is very rare [2, 3]. Because
of the low frequency of the disease, the optimal
therapeutic strategy for primary non-gastric lymphomas
is yet to be established; however, prognosis is good, and
the 5-year and 10-year overall survival rates have been
reported to be approximately 90% and 80%, respectively
[4, 5]. Radiotherapy or surgical resection is considered
to be a therapeutic strategy of limited stage MALT
lymphomas, but because of the high radiosensitivity of
MALT lymphomas, this condition can be controlled by
radiotherapy of approximately 30 Gy alone [6–8]. The
present case was of a 28-year-old Japanese woman who
desired to bear children. However, ovarian dysfunction
as an adverse event of radiotherapy for pelvic lesions can
become a serious problem. Here we report a case of a
28-year-old woman with rectal MALT lymphoma who
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safely gave birth to a baby following 30.6 Gy radiother-
apy to her whole rectum.
Case presentation
A 28-year-old Japanese woman became aware of bloody
stools from August 2013 and visited a neighborhood
clinic dedicated to internal medicine and digestive or-
gans in September 2013. An initial examination by col-
onoscopy identified elevated lesions with mild bleeding
in the Rb section of her rectum (Fig. 1). These rectal le-
sions were biopsied for analysis. Immunohistochemical
investigation of the biopsy revealed that the proliferating
cells were phenotypically characterized as CD20+,
CD79a+, CD3−, CD5−, CD10−, and cyclin D1−. Based
on these findings, she was diagnosed as having MALT
lymphoma. A complete blood count revealed a
hemoglobin level of 10.6 g/dl. Biochemical examination
of her blood showed a lactate dehydrogenase (LDH)
level of 102 IU/l and a soluble interleukin-2 receptor
(sIL-2R) level of 190 U/ml (reference value, 145 to
519 U/ml). Although her hemoglobin was slightly re-
duced, LDH and sIL-2R were within the normal range.
She was referred to the Department of Gastroenterology
of a general hospital in October 2013. No enlargement of
regional nodes or distant metastasis was revealed by
positron emission tomography-computed tomography
(PET-CT) and contrast-enhanced computed tomography
(CT). Finally, she was diagnosed as having Lugano I rectal
MALT lymphoma.
She was then introduced to our institute and initiated
on radiotherapy. However, she expressed a desire to
bear children and had some embryos frozen by the
Department of Obstetrics and Gynecology before be-
ing admitted to our department in February 2014.
To achieve dose constraints of 12 Gy to her entire
ovary, we used horizontally opposed pair fields for radio-
therapy to minimize the irradiation to her endometrium
and ovary. The irradiated field and dose distribution for
this case are shown in Fig. 2a and b, respectively. The
clinical target volume (CTV) was defined as the whole
rectum and it is shown in orange in Fig. 2a. The plan-
ning target volume (PTV) was defined as CTV plus
1 cm margin in all directions and it is shown in green.
The ovary and uterus are shown in yellow and pink, re-
spectively. A total dose of 30.6 Gy was given in 17 frac-
tions of 1.8 Gy by 10-Megavolt X-ray linear accelerator
to PTV and no chemotherapy was scheduled. As a re-
sult, one-third of her uterus and half of her ovary would
be outside the irradiation field. A dose volume histogram
is show in Fig. 3. The mean dose received by her uterus
and ovary was 22.5 Gy and 16.6 Gy, respectively. We de-
termined that a hot area of a maximum of 130% spread-
ing to the soft tissue (subcutaneous fat) was acceptable
as the actual dose was 39.8 Gy. Mild radiation dermatitis
(Grade 2) around her anus was observed as an acute ad-
verse event.
She completed radiotherapy and was discharged in
March 2014, but returned to the Department of
Obstetrics and Gynecology in May 2014 due to amenor-
rhea. A female hormone test revealed a reduction in es-
trogen level and an increase in follicle-stimulating
hormone level. She was thus diagnosed as having prema-
ture ovarian failure. Kaufmann therapy was then
commenced. After approximately 1 year of treatment,
positive pregnancy was confirmed (April 2015), and she
revisited the clinic. A gestational sac was confirmed by
ultrasound examination, and the second month of preg-
nancy was diagnosed. Surprisingly, she had conceived
naturally. Finally, she safely gave birth to a baby girl
without congenital abnormalities in October 2015.
Discussion
Non-gastric MALT lymphomas can occur in the colon,
lung, thyroid gland, salivary glands, mammary gland,
and ophthalmologic fields. Primary rectal MALT lymph-
oma is a particularly rare disease, accounting for less
than 1% of all MALT lymphomas [2, 3]. Rectal MALT
lymphomas tend to show elevated lesions, such as
polyps or submucosal tumors, during endoscopy, and
our case presented with similar characteristic polypoid
lesions [9]. Because of the low incidence of the disease,
conducting large clinical trials is difficult. Therefore, the
optimal therapeutic strategy for this type of lymphoma is
yet to be established, and therapeutic strategy is cur-
rently determined according to the lesion site or clinical
stage. In the case of limited stage MALT lymphomas,
Fig. 1 Colonoscopy showing elevated lesions with mild bleeding in
the Rb section of the rectum
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local therapy, such as radiotherapy or surgery, is gener-
ally the principal course of action. However, MALT
lymphomas can be well controlled by radiotherapy alone
with approximately 30 Gy, and surgery is considered ex-
cessive with regard to organ preservation and the post-
operative quality of life. The therapeutic strategy used in
the present case was radiation therapy, and a total dose
of 30.6 Gy was given in 17 fractions to the whole rec-
tum. After 9 months of radiotherapy, our patient was
endoscopically examined, and all the lesions had under-
gone complete remission. No severe gastrointestinal late
adverse events, such as rectal bleeding, have yet been
observed.
A critical point of this case was our patient’s desire to
bear children, and we wanted to meet her desire, as well
as gain good control over her rectal MALT lymphoma.
However, when radiotherapy is focused onto the pelvic
cavity, ovarian dysfunction as an adverse event of radio-
therapy becomes a serious problem. Therefore, we per-
formed radiotherapy using horizontally opposed pair
fields, which goes against the era of three-dimensional
radiotherapy. Our treatment procedure had two pur-
poses. First, we tried to minimize the amount of irradi-
ation exposure to her ovaries. Although she had frozen
embryos stored, we wanted to preserve her ovarian func-
tion as much as possible in an effort to give her a chance
of a natural pregnancy. Second, we attempted to
minimize the amount of irradiation exposure to her
endometrium, such that we could maximize the chance
of normal implantation if she could not become preg-
nant naturally and needed to use her frozen embryos.
Schuck et al. reported that when the whole ovary is ir-
radiated more than 15 Gy, ovarian dysfunction occurs in
almost all patients. In addition, when one side of the
ovary is preserved, ovarian dysfunction occurs in ap-
proximately half of all patients [10]. The mean dose
absorbed by the ovary in this patient’s case was 16.6 Gy,
although our treatment procedure was successfully
achieved by removing half of her ovary from the
irradiation field. Therefore, half of her ovary was not
Fig. 2 a The irradiation field. Clinical target volume was defined as the whole rectum and is shown in orange. Planning target volume was
defined as clinical target volume plus a 1 cm margin in all directions and is shown in green. The ovary and uterus are shown in yellow and pink,
respectively. b Dose distribution of the axial cross section. Although a hot area of more than 110% spread to both sides of the soft tissue, the
ventral side of the ovary and uterus remained outside the irradiation field
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completely irradiated, and we expected her ovarian func-
tion to be preserved with a probability of 50%. Following
our procedure, she developed temporary ovarian dys-
function; Kaufmann therapy, a replacement therapy
comprising estrogen and progesterone for ovarian amen-
orrhea, was commenced. We consider that preserving
half of her ovary using horizontally opposed pair fields
for radiotherapy was a key benefit in terms of ovulation
and natural pregnancy. On the other hand, the tolerance
dose of the endometrium is not yet known and, conse-
quently, there is a potential risk of implantation disor-
ders. Because we could not identify her endometrium by
CT, the irradiation dose to her endometrium could not
be determined using a dose volume histogram. However,
we believe that removing one-third of her uterus from
the irradiation field was a key contributor to retaining
normal implantation, thereby leading to the safe birth of
a baby girl. Although the full dose of 30.6 Gy was used
to irradiate her vagina, she delivered her baby without
any problem. Therefore, we consider a total dose of ap-
proximately 30 Gy does not cause adverse effects to the
vagina.
Conclusions
Here we report the case of a 28-year-old woman with a
rectal MALT lymphoma who safely gave birth to a baby
following 30.6 Gy radiotherapy to her whole rectum.
This case involves several rare points. First, there is a
low incidence of primary rectal MALT lymphoma
among cases of MALT lymphoma. Second, ovarian func-
tion could be preserved by removing half of her ovary
from the irradiation field using horizontally opposed pair
fields. Finally, by removing one-third of her uterus from
the irradiation field, we could preserve normal implant-
ation, which enabled her to give birth naturally. We be-
lieve that this case is extremely rare and will be of global
interest, and we are proud to be able to report the con-
trol of rectal MALT lymphoma and the safe birth of a
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